I think the BAM study is bound to come back with positive numbers - expected capex inflation aside.
Though I was alarmed about the MD's recent comments about getting Mitsu or other end users to invest in it. With the funds we have now, and possible ECA loans/critical mineral gov funding available I would have thought getting this project up and running with minimal further dilution ought to be the goal of management. Makes me think there remains upside here, but it may only be in reaching the previous share price high - which would be bitterly disappointing.
Management remains my biggest concern with RNU. The resource is ideal.
- Forums
- ASX - By Stock
- RNU
- General Discussions
General Discussions, page-24031
-
-
- There are more pages in this discussion • 6,596 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNU (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
-0.001(1.02%) |
Mkt cap ! $246.5M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 9.6¢ | $357.0K | 3.626M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 89999 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 40000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 89999 | 0.097 |
3 | 331054 | 0.096 |
5 | 463192 | 0.095 |
4 | 246608 | 0.094 |
2 | 74736 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 40000 | 2 |
0.105 | 1232604 | 19 |
0.110 | 831519 | 15 |
0.115 | 563490 | 12 |
0.120 | 2300622 | 14 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RNU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online